Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.96 INR | +3.31% |
|
-0.37% | +21.15% |
Valuation
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 117.3 | 88.46 | 29.58 | 38.68 | 177.8 | 181.7 |
Enterprise Value (EV) 1 | 117.3 | 88.5 | 29.9 | 38.9 | 181.5 | 182.7 |
P/E ratio | 131 x | -26.2 x | -9.68 x | -38.4 x | -44.1 x | 130 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 34.2 x | 97.1 x | 46.8 x | - | 291,434 x | 49 x |
EV / Revenue | 34.2 x | 97.1 x | 47.3 x | - | 297,464 x | 49.3 x |
EV / EBITDA | -128 x | -45.5 x | -12.3 x | -62.6 x | -48.3 x | 93.2 x |
EV / FCF | -24.5 x | -163 x | -13 x | 80.6 x | -71.4 x | 78.6 x |
FCF Yield | -4.08% | -0.62% | -7.71% | 1.24% | -1.4% | 1.27% |
Price to Book | 11.7 x | 13.3 x | 8.17 x | 27.1 x | -88.8 x | -280 x |
Nbr of stocks (in thousands) | 6,500 | 6,500 | 6,500 | 6,500 | 6,500 | 6,500 |
Reference price 2 | 18.05 | 13.61 | 4.550 | 5.950 | 27.35 | 27.95 |
Announcement Date | 9/7/18 | 9/4/19 | 12/21/20 | 11/8/21 | 9/8/22 | 9/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 3.429 | 0.9112 | 0.6316 | - | 0.00061 | 3.706 |
EBITDA 1 | -0.9195 | -1.947 | -2.44 | -0.6219 | -3.76 | 1.961 |
EBIT 1 | -1.056 | -2.47 | -2.848 | -0.9753 | -3.926 | 1.795 |
Operating Margin | -30.78% | -271.08% | -450.88% | - | -643,551.64% | 48.43% |
Earnings before Tax (EBT) 1 | 1.093 | -3.41 | -3.098 | -1.034 | -3.999 | 1.73 |
Net income 1 | 0.8929 | -3.349 | -3.039 | -1.007 | -4.012 | 1.4 |
Net margin | 26.04% | -367.51% | -481.18% | - | -657,682.13% | 37.78% |
EPS 2 | 0.1374 | -0.5200 | -0.4700 | -0.1549 | -0.6200 | 0.2154 |
Free Cash Flow 1 | -4.79 | -0.5444 | -2.304 | 0.4828 | -2.541 | 2.326 |
FCF margin | -139.69% | -59.74% | -364.83% | - | -416,480.16% | 62.75% |
FCF Conversion (EBITDA) | - | - | - | - | - | 118.59% |
FCF Conversion (Net income) | - | - | - | - | - | 166.12% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/7/18 | 9/4/19 | 12/21/20 | 11/8/21 | 9/8/22 | 9/6/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.04 | 0.32 | 0.23 | 3.68 | 1.03 |
Net Cash position 1 | 0.04 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -0.019 x | -0.1321 x | -0.3656 x | -0.9782 x | 0.5247 x |
Free Cash Flow 1 | -4.79 | -0.54 | -2.3 | 0.48 | -2.54 | 2.33 |
ROE (net income / shareholders' equity) | 9.36% | -40.2% | -59.1% | -39.9% | 1,395% | -103% |
ROA (Net income/ Total Assets) | -5.86% | -14.3% | -22.9% | -14% | -105% | 56.9% |
Assets 1 | -15.23 | 23.4 | 13.26 | 7.183 | 3.825 | 2.462 |
Book Value Per Share 2 | 1.540 | 1.020 | 0.5600 | 0.2200 | -0.3100 | -0.1000 |
Cash Flow per Share 2 | 0.0500 | 0.1000 | 0.0400 | 0.0100 | 0.0500 | 0.1000 |
Capex 1 | 1.78 | 0.25 | 0.06 | - | - | - |
Capex / Sales | 51.77% | 27.06% | 9.94% | - | - | - |
Announcement Date | 9/7/18 | 9/4/19 | 12/21/20 | 11/8/21 | 9/8/22 | 9/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+21.15% | 2.26M | |
+15.81% | 6.87B | |
+7.20% | 3.64B | |
+71.91% | 2.38B | |
+11.82% | 2.35B | |
+21.08% | 2.33B | |
+6.50% | 2.31B | |
+5.54% | 1.76B | |
+34.89% | 1.71B | |
-0.90% | 1.58B |
- Stock Market
- Equities
- RAJKSYN6 Stock
- Financials Rajkamal Synthetics Limited